Cargando…
Teduglutide in amyloidosis‐associated intestinal failure
Amyloidosis is a heterogeneous disease characterized by tissue deposition of abnormally folded fibrillary proteins that can manifest itself by a wide variety of symptoms depending on the affected organs. GI involvement among amyloidosis patients is common. Its clinical manifestation often presents w...
Autores principales: | Luhn, Clara, Agis, Hermine, Hütterer, Elisabeth, Simonitsch‐Klupp, Ingrid, Dawoud, Christopher, Stift, Anton, Harpain, Felix |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10433832/ https://www.ncbi.nlm.nih.gov/pubmed/37601424 http://dx.doi.org/10.1002/ccr3.7653 |
Ejemplares similares
-
Bridging intestinal failure with Teduglutide – A case report
por: Schlager, Lukas, et al.
Publicado: (2021) -
Teduglutide in short bowel syndrome patients: A way back to normal life?
por: Harpain, Felix, et al.
Publicado: (2021) -
Use of Teduglutide in Children With Intestinal Failure: A Systematic Review
por: Gigola, Francesca, et al.
Publicado: (2022) -
Long-Term Teduglutide for the Treatment of Patients With Intestinal Failure Associated With Short Bowel Syndrome
por: Schwartz, Lauren K, et al.
Publicado: (2016) -
Effects of Teduglutide on Diarrhea in Pediatric Patients with Short Bowel Syndrome-Associated Intestinal Failure
por: Fifi, Amanda, et al.
Publicado: (2023)